Drug recall · November 11, 2020
Olanzapine Orally Disintegrating Tablets recall
Why: Subpotent
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32
- Lots / codes
Lot # AE119001A, exp. date 01/2021
- Quantity
- 23,616 blister packs
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Product was distributed nationwide
- Initiated
- October 26, 2020 · Voluntary: Firm initiated
- Classified
- November 5, 2020
- Reported
- November 11, 2020
- Ended
- August 11, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olanzapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.